Literature DB >> 22339899

Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP).

Claudine T Jurkovitz1, Daniel Elliott, Suying Li, Georges Saab, Andrew S Bomback, Keith C Norris, Shu-Cheng Chen, Peter A McCullough, Adam T Whaley-Connell.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is a well-known risk factor for cardiovascular mortality, but little is known about the association between physician utilization and cardiovascular disease risk-factor control in patients with CKD. We used 2005-2010 data from the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) to examine this association at first and subsequent screenings.
METHODS: Control of risk factors was defined as control of blood pressure, glycemia, and cholesterol levels. We used multinomial logistic regression to examine the association between participant characteristics and seeing a nephrologist after adjusting for kidney function and paired t tests or McNemar tests to compare characteristics at first and second screenings.
RESULTS: Of 90,009 participants, 61.3% had a primary care physician only, 2.9% had seen a nephrologist, and 15.3% had seen another specialist. The presence of 3 risk factors (hypertension, diabetes, and hypercholesterolemia) increased from 26.8% in participants with CKD stages 1-2 to 31.9% in those with stages 4-5. Target levels of all risk factors were achieved in 7.2% of participants without a physician, 8.3% of those with a primary care physician only, 9.9% of those with a nephrologist, and 10.3% of those with another specialist. Of up to 7,025 participants who met at least one criterion for nephrology consultation at first screening, only 12.3% reported seeing a nephrologist. Insurance coverage was associated strongly with seeing a nephrologist. Of participants who met criteria for nephrology consultation, 406 (5.8%) returned for a second screening, of whom 19.7% saw a nephrologist. The percentage of participants with all risk factors controlled was higher at the second screening (20.9% vs 13.3%).
CONCLUSION: Control of cardiovascular risk factors is poor in the KEEP population. The percentage of participants seeing a nephrologist is low, although better after the first screening. Identifying communication barriers between nephrologists and primary care physicians may be a new focus for KEEP.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22339899      PMCID: PMC3654535          DOI: 10.1053/j.ajkd.2011.11.019

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  28 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Multidisciplinary team care may slow the rate of decline in renal function.

Authors:  Elizabeth A Bayliss; Bharati Bhardwaja; Colleen Ross; Arne Beck; Diane M Lanese
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 8.237

3.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

4.  Control of hypertension in adults with chronic kidney disease in the United States.

Authors:  Carmen A Peralta; Leroi S Hicks; Glenn M Chertow; John Z Ayanian; Eric Vittinghoff; Feng Lin; Michael G Shlipak
Journal:  Hypertension       Date:  2005-04-25       Impact factor: 10.190

Review 5.  Late referral of patients with chronic kidney disease: no time to waste.

Authors:  Ben Sprangers; Pieter Evenepoel; Yves Vanrenterghem
Journal:  Mayo Clin Proc       Date:  2006-11       Impact factor: 7.616

6.  Identification and referral of patients with progressive CKD: a national study.

Authors:  L Ebony Boulware; Misty U Troll; Bernard G Jaar; Donna I Myers; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2006-08       Impact factor: 8.860

7.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

8.  Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP).

Authors:  Wendy Weinstock Brown; Rosalind M Peters; Suzanne E Ohmit; William F Keane; Allan Collins; Shu-Chen Chen; Karren King; Michael J Klag; Donald A Molony; John M Flack
Journal:  Am J Kidney Dis       Date:  2003-07       Impact factor: 8.860

9.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

10.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

View more
  11 in total

Review 1.  Socioeconomic disparities in chronic kidney disease.

Authors:  Susanne B Nicholas; Kamyar Kalantar-Zadeh; Keith C Norris
Journal:  Adv Chronic Kidney Dis       Date:  2015-01       Impact factor: 3.620

2.  National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summary.

Authors:  Adam T Whaley-Connell; Joseph A Vassalotti; Allan J Collins; Shu-Cheng Chen; Peter A McCullough
Journal:  Am J Kidney Dis       Date:  2012-03       Impact factor: 8.860

3.  Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report.

Authors:  Adam T Whaley-Connell; Manjula Kurella Tamura; Claudine T Jurkovitz; Mikhail Kosiborod; Peter A McCullough
Journal:  Am J Kidney Dis       Date:  2013-04       Impact factor: 8.860

4.  Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Claudine T Jurkovitz; Suying Li; Keith C Norris; Georges Saab; Andrew S Bomback; Adam T Whaley-Connell; Peter A McCullough
Journal:  Am J Kidney Dis       Date:  2013-04       Impact factor: 8.860

5.  Multicenter epidemiological study to assess the population of CKD patients in Greece: results from the PRESTAR study.

Authors:  Konstantinos Sombolos; Demitrios Tsakiris; John Boletis; Demetrios Vlahakos; Kostas C Siamopoulos; Vassilios Vargemezis; Pavlos Nikolaidis; Christos Iatrou; Eugene Dafnis; Konstantinos Xynos; Christos Argyropoulos
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

6.  Provision of care for chronic kidney disease by non-nephrologists in a developing nation: a national survey.

Authors:  S Al Shamsi; A Al Dhanhani; M M Sheek-Hussein; O Bakoush
Journal:  BMJ Open       Date:  2016-08-01       Impact factor: 2.692

7.  A systematic review of sleep disorders in patients with chronic kidney disease undergoing hemodialysis.

Authors:  Nina Teixeira Fonseca; Jessica Julioti Urbano; Sergio Roberto Nacif; Anderson Soares Silva; Roger Andre Oliveira Peixoto; Giovanni Julioti Urbano; Ezequiel Fernandes Oliveira; Israel Reis Santos; Claudia Santos Oliveira; Giuseppe Insalaco; Luis Vicente Franco Oliveira
Journal:  J Phys Ther Sci       Date:  2016-07-29

8.  Effects of physician's specialty on regular chronic kidney disease care in predialysis: A population-based cross-sectional study.

Authors:  Ming-Yen Lin; Charles Tzu-Chi Lee; Mei-Chuan Kuo; Shang-Jyh Hwang; Hung-Chun Chen; Yi-Wen Chiu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 9.  Raising awareness of acute kidney injury: a global perspective of a silent killer.

Authors:  Andrew J P Lewington; Jorge Cerdá; Ravindra L Mehta
Journal:  Kidney Int       Date:  2013-05-01       Impact factor: 10.612

10.  Cardiovascular risk and mortality in end-stage renal disease patients undergoing dialysis: sleep study, pulmonary function, respiratory mechanics, upper airway collapsibility, autonomic nervous activity, depression, anxiety, stress and quality of life: a prospective, double blind, randomized controlled clinical trial.

Authors:  Israel dos Reis Santos; Aline Roberta Danaga; Isabella de Carvalho Aguiar; Ezequiel Fernandes Oliveira; Ismael Souza Dias; Jessica Julioti Urbano; Aline Almeida Martins; Leonardo Macario Ferraz; Nina Teixeira Fonsêca; Virgilio Fernandes; Vinicius Alves Thomaz Fernandes; Viviane Cristina Delgado Lopes; Fernando Sérgio Studart Leitão Filho; Sérgio Roberto Nacif; Paulo de Tarso Camillo de Carvalho; Luciana Maria Malosá Sampaio; Lílian Christiane Giannasi; Salvatore Romano; Giuseppe Insalaco; Ana Karina Fachini Araujo; Humberto Dellê; Nadia Karina Guimarães Souza; Daniel Giannella-Neto; Luis Vicente Franco Oliveira
Journal:  BMC Nephrol       Date:  2013-10-08       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.